Analyst Consensus ?
ConsensusBuy49 ratings
Bullish3367.3%
Neutral1632.7%
Bearish00.0%
FN2 Earnings Intelligence
Edwards Lifesciences Corporation analyst ratings
Edwards Lifesciences Corporation (EW) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$85.76Current
$70Low
$100.08Average
$140High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Piper Sandler | Overweight | Overweight | Maintain | Jul 24, 2026 |
| Leerink Partners | Outperform | Market Perform | Upgrade | Jul 24, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 24, 2026 |
| Truist Securities | Hold | Hold | Maintain | Jul 16, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 15, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 13, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 8, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 6, 2026 |
| BTIG | Buy | Buy | Maintain | Jun 30, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jun 2, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 27, 2026 |
| Canaccord Genuity | Hold | Hold | Maintain | Apr 24, 2026 |
| Baird | Neutral | Neutral | Maintain | Apr 24, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 11, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 11, 2026 |
| Stifel | Buy | Buy | Maintain | Jan 20, 2026 |
| UBS | Neutral | Neutral | Maintain | Jan 12, 2026 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Oct 29, 2025 |
| Jefferies | Buy | Hold | Upgrade | Oct 29, 2025 |
| Oppenheimer | Perform | Outperform | Downgrade | Oct 8, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 25, 2025 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 15, 2025 |
| B of A Securities | Buy | Neutral | Upgrade | Dec 16, 2024 |
| OTR Global | Positive | Mixed | Upgrade | Mar 26, 2024 |
| Raymond James | Market Perform | Outperform | Downgrade | Feb 6, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | Apr 27, 2022 |
| Bernstein | Outperform | Market Perform | Upgrade | Mar 16, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Jan 7, 2022 |
| Atlantic Equities | Neutral | Neutral | Maintain | Apr 15, 2021 |
| CFRA | Buy | Buy | Maintain | Apr 24, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jan 31, 2020 |
| PiperJaffray | Overweight | Overweight | Maintain | Dec 9, 2019 |
| Bank of America | Buy | Buy | Maintain | Oct 24, 2019 |
| Piper Jaffray | Overweight | Overweight | Maintain | Sep 23, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 24, 2019 |
| Guggenheim | Neutral | Buy | Downgrade | Oct 2, 2018 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Feb 2, 2018 |
| BTIG Research | Neutral | Buy | Downgrade | Feb 2, 2017 |
| Cowen & Co. | Outperform | Outperform | Maintain | Dec 7, 2016 |
| Northland Securities | Outperform | Market Perform | Upgrade | Nov 8, 2016 |
| Northland Capital Markets | Outperform | Market Perform | Upgrade | Nov 8, 2016 |
| Leerink Swann | Outperform | Outperform | Maintain | Apr 4, 2016 |
| Nomura | Buy | Buy | Maintain | Mar 17, 2016 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Mar 7, 2016 |
| Sterne Agee | Neutral | Buy | Downgrade | Nov 7, 2014 |
| CRT Capital | Buy | Buy | Maintain | Oct 23, 2014 |
| Wunderlich Securities | Hold | Hold | Maintain | Apr 24, 2013 |
| Wunderlich | Hold | Hold | Maintain | Apr 24, 2013 |
| Lazard | Neutral | Buy | Downgrade | Apr 24, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $85.76. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $110 | $83.04 | +28.3% | Jul 28, 2026 |
| Piper Sandler | Analyst unavailable | $101 | $83.82 | +17.8% | Jul 24, 2026 |
| Leerink Partners | Mike Kratky | $101 | $83.82 | +17.8% | Jul 24, 2026 |
| Truist Financial | Richard Newitter | $95 | $86.78 | +10.8% | Jul 16, 2026 |
| RBC Capital | Analyst unavailable | $110 | $92.02 | +28.3% | Jul 13, 2026 |
| Evercore ISI | Analyst unavailable | $100 | $93.12 | +16.6% | Jul 6, 2026 |
| BTIG | Marie Thibault | $110 | $91.18 | +28.3% | Jun 30, 2026 |
| Barclays | Analyst unavailable | $110 | $84.15 | +28.3% | Apr 27, 2026 |
| Truist Financial | Analyst unavailable | $90 | $83.15 | +4.9% | Apr 24, 2026 |
| Evercore ISI | Vijay Kumar | $93 | $83.12 | +8.4% | Apr 24, 2026 |
| BTIG | Analyst unavailable | $100 | $79.72 | +16.6% | Apr 24, 2026 |
| Canaccord Genuity | William Plovanic | $85 | $79.72 | -0.9% | Apr 24, 2026 |
| Mizuho Securities | Analyst unavailable | $95 | $77.28 | +10.8% | Apr 13, 2026 |
| Truist Financial | Richard Newitter | $89 | $76.85 | +3.8% | Feb 11, 2026 |
| Goldman Sachs | David Roman | $95 | $77.05 | +10.8% | Feb 11, 2026 |
| Piper Sandler | Analyst unavailable | $100 | $77.05 | +16.6% | Feb 11, 2026 |
| UBS | Danielle Antalffy | $94 | $81.62 | +9.6% | Feb 4, 2026 |
| Stifel Nicolaus | Analyst unavailable | $110 | $84.35 | +28.3% | Jan 20, 2026 |
| Piper Sandler | Analyst unavailable | $98 | $84.35 | +14.3% | Jan 20, 2026 |
| UBS | Danielle Antalffy | $95 | $83.58 | +10.8% | Jan 12, 2026 |
| Robert W. Baird | Analyst unavailable | $90 | $83.69 | +4.9% | Jan 12, 2026 |
| Barclays | Analyst unavailable | $104 | $85.13 | +21.3% | Jan 12, 2026 |
| Goldman Sachs | David Roman | $108 | $84.58 | +25.9% | Jan 9, 2026 |
| Stifel Nicolaus | Rick Wise | $105 | $85.85 | +22.4% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $94 | $84.34 | +9.6% | Jan 5, 2026 |
| Wells Fargo | Analyst unavailable | $100 | $84.84 | +16.6% | Dec 18, 2025 |
| Canaccord Genuity | William Plovanic | $87 | $85.32 | +1.4% | Dec 17, 2025 |
| Robert W. Baird | David Rescott | $87 | $83.38 | +1.4% | Dec 16, 2025 |
| Barclays | Analyst unavailable | $103 | $86.19 | +20.1% | Dec 8, 2025 |
| UBS | Analyst unavailable | $92 | $86.58 | +7.3% | Dec 5, 2025 |
| RBC Capital | Shagun Singh | $100 | $87.34 | +16.6% | Dec 5, 2025 |
| Robert W. Baird | David Rescott | $88 | $85.78 | +2.6% | Dec 5, 2025 |
| Canaccord Genuity | William Plovanic | $89 | $85.78 | +3.8% | Dec 5, 2025 |
| Wells Fargo | Larry Biegelsen | $96 | $85.78 | +11.9% | Dec 5, 2025 |
| Stifel Nicolaus | Rick Wise | $100 | $85.78 | +16.6% | Dec 5, 2025 |
| Truist Financial | Richard Newitter | $92 | $85.78 | +7.3% | Dec 5, 2025 |
| BTIG | Marie Thibault | $103 | $85.78 | +20.1% | Dec 4, 2025 |
| Bernstein | Lee Hambright | $90 | $82.45 | +4.9% | Nov 3, 2025 |
| UBS | Analyst unavailable | $90 | $82.45 | +4.9% | Nov 3, 2025 |
| Canaccord Genuity | William Plovanic | $84 | $82.45 | -2.1% | Nov 3, 2025 |
| Raymond James | Jayson Bedford | $96 | $82.45 | +11.9% | Nov 3, 2025 |
| National Bank | Analyst unavailable | $92 | $82.46 | +7.3% | Oct 31, 2025 |
| Goldman Sachs | Analyst unavailable | $104 | $84.48 | +21.3% | Oct 31, 2025 |
| RBC Capital | Analyst unavailable | $95 | $83.29 | +10.8% | Oct 31, 2025 |
| Robert W. Baird | David Rescott | $83 | $83.29 | -3.2% | Oct 31, 2025 |
| Barclays | Analyst unavailable | $99 | $83.48 | +15.4% | Oct 31, 2025 |
| Jefferies | Matthew Taylor | $98 | $82.19 | +14.3% | Oct 29, 2025 |
| Truist Financial | Analyst unavailable | $87 | $83.08 | +1.4% | Oct 28, 2025 |
| Truist Financial | Analyst unavailable | $82 | $80.82 | -4.4% | Oct 27, 2025 |
| Evercore ISI | Analyst unavailable | $88 | $76.56 | +2.6% | Oct 7, 2025 |
| Stifel Nicolaus | Rick Wise | $85 | $74.41 | -0.9% | Sep 22, 2025 |
| Canaccord Genuity | William Plovanic | $75 | $76.04 | -12.5% | Apr 25, 2025 |
| Stifel Nicolaus | Rick Wise | $90 | $71.13 | +4.9% | Jan 29, 2025 |
| Bernstein | Lee Hambright | $74 | $74.15 | -13.7% | Jan 8, 2025 |
| Bernstein | Lee Hambright | $72 | $72.62 | -16.0% | Dec 5, 2024 |
| Truist Financial | Richard Newitter | $78 | $72.64 | -9.0% | Dec 5, 2024 |
| Canaccord Genuity | William Plovanic | $68 | $73.26 | -20.7% | Dec 5, 2024 |
| Goldman Sachs | David Roman | $80 | $68.63 | -6.7% | Oct 30, 2024 |
| Bank of America Securities | Travis Steed | $75 | $68.63 | -12.5% | Oct 30, 2024 |
| Citigroup | Joanne Wuensch | $81 | $69.05 | -5.6% | Oct 28, 2024 |
| Robert W. Baird | David Rescott | $73 | $69.63 | -14.9% | Oct 15, 2024 |
| Morgan Stanley | Patrick Wood | $70 | $68.26 | -18.4% | Oct 11, 2024 |
| Canaccord Genuity | William Plovanic | $66 | $65.49 | -23.0% | Oct 7, 2024 |
| Jefferies | Matthew Taylor | $70 | $67.23 | -18.4% | Sep 18, 2024 |
| Truist Financial | Richard Newitter | $71 | $68.13 | -17.2% | Sep 13, 2024 |
| Barclays | Matt Miksic | $80 | $66.81 | -6.7% | Sep 9, 2024 |
| Wells Fargo | Larry Biegelsen | $80 | $66.81 | -6.7% | Sep 9, 2024 |
| Daiwa | Narumi Nakagiri | $72 | $63.64 | -16.0% | Jul 31, 2024 |
| Citigroup | Joanna Wuensch | $83 | $63.74 | -3.2% | Jul 30, 2024 |
| Deutsche Bank | Pito Chickering | $85 | $60.58 | -0.9% | Jul 25, 2024 |
| Stifel Nicolaus | Rick Wise | $70 | $86.95 | -18.4% | Jul 25, 2024 |
| Piper Sandler | Adam Maeder | $73 | $86.95 | -14.9% | Jul 25, 2024 |
| Truist Financial | Richard Newitter | $110 | $89.5 | +28.3% | Jul 16, 2024 |
| Goldman Sachs | David Roman | $107 | $87.03 | +24.8% | May 30, 2024 |
| Deutsche Bank | Pito Chickering | $103 | $84.7 | +20.1% | May 14, 2024 |
| RBC Capital | Shagun Singh | $101 | $90.28 | +17.8% | Apr 15, 2024 |
| Mizuho Securities | Anthony Petrone | $105 | $91.51 | +22.4% | Apr 11, 2024 |
| Oppenheimer | Suraj Kalia | $100 | $92.85 | +16.6% | Mar 18, 2024 |
| Canaccord Genuity | Analyst unavailable | $76 | $78.21 | -11.4% | Feb 1, 2023 |
| Truist Financial | Analyst unavailable | $86 | $76.7 | +0.3% | Feb 1, 2023 |
| Morgan Stanley | Analyst unavailable | $95 | $76.32 | +10.8% | Jan 6, 2023 |
| Raymond James | Analyst unavailable | $83 | $75.32 | -3.2% | Dec 13, 2022 |
| Citigroup | Analyst unavailable | $92 | $75.26 | +7.3% | Dec 12, 2022 |
| Stifel Nicolaus | Rick Wise | $75 | $73.85 | -12.5% | Dec 5, 2022 |
| RBC Capital | Analyst unavailable | $105 | $75.98 | +22.4% | Nov 28, 2022 |
| RBC Capital | Shagun Singh Chadha | $118 | $70.87 | +37.6% | Oct 28, 2022 |
| Truist Financial | Richard Newitter | $120 | $100.54 | +39.9% | Jul 30, 2022 |
| Canaccord Genuity | Analyst unavailable | $137 | $111.59 | +59.7% | Apr 27, 2022 |
| Raymond James | Analyst unavailable | $124 | $111.86 | +44.6% | Apr 27, 2022 |
| RBC Capital | Analyst unavailable | $135 | $116.27 | +57.4% | Apr 27, 2022 |
| Leerink Partners | Analyst unavailable | $138 | $116.27 | +60.9% | Apr 27, 2022 |
| Evercore ISI | Vijay Kumar | $126 | $120.36 | +46.9% | Apr 6, 2022 |
| Bank of America Securities | Travis Steed | $130 | $111.98 | +51.6% | Mar 3, 2022 |
| Leerink Partners | Danielle Antalffy | $130 | $101.96 | +51.6% | Jan 27, 2022 |
| Stifel Nicolaus | Rick Wise | $120 | $101.96 | +39.9% | Jan 27, 2022 |
| Morgan Stanley | Cecilia Furlong | $136 | $101.96 | +58.6% | Jan 27, 2022 |
| Deutsche Bank | Pito Chickering | $113 | $108.63 | +31.8% | Jan 26, 2022 |
| Credit Suisse | Matt Miksic | $140 | $122.3 | +63.2% | Jan 7, 2022 |
| J.P. Morgan | Robbie Marcus | $140 | $122.12 | +63.2% | Dec 17, 2021 |
| Oppenheimer | Suraj Kalia | $135 | $120.34 | +57.4% | Dec 9, 2021 |
| Wells Fargo | Larry Biegelsen | $133 | $120.34 | +55.1% | Dec 9, 2021 |
| Cowen & Co. | Josh Jennings | $140 | $120.34 | +63.2% | Dec 9, 2021 |
| Jefferies | Anthony Petrone | $135 | $119.54 | +57.4% | Nov 8, 2021 |
Track every rating change on EW the moment it posts. Free to start.
Start free